Acorah Software Products - Accounts Production 19.4.300 false true 30 November 2024 1 December 2023 false 1 December 2024 30 November 2025 30 November 2025 7454360 Dr Jason Amogbokpa Mrs Christianna Amogbokpa iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 7454360 2024-11-30 7454360 2025-11-30 7454360 2024-12-01 2025-11-30 7454360 frs-core:CurrentFinancialInstruments 2025-11-30 7454360 frs-core:ComputerEquipment 2025-11-30 7454360 frs-core:ComputerEquipment 2024-12-01 2025-11-30 7454360 frs-core:ComputerEquipment 2024-11-30 7454360 frs-core:PlantMachinery 2024-12-01 2025-11-30 7454360 frs-core:ShareCapital 2025-11-30 7454360 frs-core:RetainedEarningsAccumulatedLosses 2025-11-30 7454360 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 7454360 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 7454360 frs-bus:SmallEntities 2024-12-01 2025-11-30 7454360 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 7454360 frs-bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 7454360 frs-bus:Director1 2024-12-01 2025-11-30 7454360 frs-bus:Director2 2024-12-01 2025-11-30 7454360 frs-countries:EnglandWales 2024-12-01 2025-11-30 7454360 2023-11-30 7454360 2024-11-30 7454360 2023-12-01 2024-11-30 7454360 frs-core:CurrentFinancialInstruments 2024-11-30 7454360 frs-core:ShareCapital 2024-11-30 7454360 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30
J Medica Ltd
Financial Statements
For The Year Ended 30 November 2025
Atiene Aghegho & Co
18 Beatrice Road
Finsbury Park
London
N4 4PD
J Medica Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2—3

Page 1
J Medica Ltd
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 7454360

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 539 |  | 718
|  |  | 539 |  | 718
CURRENT ASSETS
Cash at bank and in hand |  | 470 |  | 625 |
|  | 470 |  | 625 |
Creditors: Amounts Falling Due Within One Year | 5 | (2,284 ) |  | (840 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (1,814 ) |  | (215 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | (1,275 ) |  | 503
NET (LIABILITIES)/ASSETS |  |  | (1,275 ) |  | 503
CAPITAL AND RESERVES
Called up share capital | 6 |  | 100 |  | 100
Profit and Loss Account |  |  | (1,375 ) |  | 403
SHAREHOLDERS' FUNDS |  |  | (1,275) |  | 503

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Jason Amogbokpa Director
24/08/2026

The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
J Medica Ltd
Notes to the Financial Statements
For The Year Ended 30 November 2025
Notes to the Financial Statements
1. General Information
J Medica Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 7454360 . The registered office is 22 Gleeson Drive, Orpington, Kent, BR6 9LJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover includes revenue earned from the provision of medical services.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 25% reducing balance
Computer Equipment | 25% reducing balance

3. Average Number of Employees
Average number of employees, including directors, during the year was as 2.

| 2025 |  | 2024
--- | --- | --- | ---
Office and administration | 1 |  | 1
Manufacturing | 1 |  | 1
| 2 |  | 2

4. Tangible Assets

| Computer Equipment
--- | ---
| £
Cost
As at 1 December 2024 | 9,442
As at 30 November 2025 | 9,442
Depreciation
As at 1 December 2024 | 8,724
Provided during the period | 179
As at 30 November 2025 | 8,903
Net Book Value
As at 30 November 2025 | 539
As at 1 December 2024 | 718

Page 2
Page 3
J Medica Ltd
Notes to the Financial Statements (continued)
For The Year Ended 30 November 2025
5. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Accruals | 625 |  | 650
Directors' loan accounts | 1,659 |  | 190
| 2,284 |  | 840

6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

7. Dividends
Page 3